Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/2000
07/26/2000CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases
07/26/2000CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases
07/26/2000CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists
07/26/2000CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
07/26/2000CN1261349A Chalcones having antiproliferactive activity
07/26/2000CN1261285A CD 154 blockade therapy for therapeutic protein inhibitor syndrome
07/26/2000CN1261281A Peptide parathyroid hormone analogs
07/26/2000CN1261280A Improved methods for processing activated protein C
07/26/2000CN1261279A Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
07/26/2000CN1261278A Methods for treating inflammatory diseases using padprt inhibitors
07/26/2000CN1261277A Novel substituted imidazole compounds
07/26/2000CN1261276A Protease inhibitors
07/26/2000CN1261274A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them.
07/26/2000CN1261073A Tricyclooxime ethers, preparations thereof and medicinal compositions containing them
07/26/2000CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical
07/26/2000CN1054850C Piperazine compounds used in therapy
07/26/2000CN1054848C New benzopyran derivatives, their process of preparation and pharmaceutical compositions
07/26/2000CN1054845C Quinoline compounds, their preparing methods and medicinal compositions
07/26/2000CN1054844C N-substituted azabicycloheptane derivatives, their preparation and use
07/26/2000CN1054742C Improvements in or relating to benzothiophenes
07/26/2000CA2296965A1 Use of bacterium for manufacture of a vaccine
07/25/2000US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
07/25/2000US6093822 5-arylindole derivatives
07/25/2000US6093748 Applying to an area of skin from which reduced hair growth is desired a dermatologically acceptable composition containing a non-steroidal suppressor of angiogenesis
07/25/2000US6093743 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
07/25/2000US6093740 Therapeutic treatment for skin disorders
07/25/2000US6093738 Imidazo(1,2-d)-thiadiazole compounds; peptic ulcer treatment
07/25/2000US6093735 Selective β-3 adrenergic agonists
07/25/2000US6093733 Muscarinic receptor agonists
07/25/2000US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
07/25/2000US6093729 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
07/25/2000US6093728 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds
07/25/2000US6093718 An oxido-squalene cyclase inhibitor, anticholesterol agent for inhibiting cholesterol biosynthesis and lowering cholesterol levels in blood plasma; treating hypercholesterolemia and atherosclerosis
07/25/2000US6093713 A tyrosine kinase inhibitor for enhancing the function of a cholinergic neuron
07/25/2000US6093707 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/25/2000US6093704 Use of dopamine receptor antagonists in palliative tumor therapy
07/25/2000US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases
07/25/2000US6093693 B cell activation
07/25/2000US6093564 Methods and compositions for the selective modification of nucleic acids
07/25/2000US6093532 Method for storing a biological organ transplant graft using a benzisoselen-azoline or -azine compound
07/25/2000US6093393 Methods for preparing and using clonogenic fibroblasts and transfected clonogenic fibroblasts
07/25/2000US6093391 Peptide compositions containing polyoxyethylene-polyoxypropylene block copolymers that are useful in treatment of diseases and disorders with reduced side effects, ease in administering to desired target site,
07/25/2000US6093390 Methods for promoting functional regeneration of mammalian muscle by administering leukaemia inhibitor factor
07/25/2000CA2205285C Benzoic acid derivative and pharmaceutical composition
07/25/2000CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists
07/25/2000CA2167688C Methods and compositions for inhibiting uridine secretion
07/25/2000CA2031890C N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
07/25/2000CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
07/20/2000WO2000042429A2 In vitro model for gastrointestinal inflammation
07/20/2000WO2000042213A1 A novel method for designing protein kinase inhibitors
07/20/2000WO2000042208A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
07/20/2000WO2000042201A2 Human peptidases
07/20/2000WO2000042179A2 Complex-forming proteins
07/20/2000WO2000042175A1 Methods for making proteins containing free cysteine residues
07/20/2000WO2000042168A2 Bifidobacterium in the treatment of inflammatory disease
07/20/2000WO2000042074A1 Anti-ccr4 antibodies and methods of use therefor
07/20/2000WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
07/20/2000WO2000042072A2 Polypeptide variants with altered effector function
07/20/2000WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response
07/20/2000WO2000042070A1 Mammalian alpha-helical protein - 12
07/20/2000WO2000042066A1 Method of purifying whey of lactic acid fermentation by electrodialysis
07/20/2000WO2000042064A1 Peptides for inhibiting hpv e6 proteins
07/20/2000WO2000042060A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors
07/20/2000WO2000042059A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
07/20/2000WO2000042053A1 Derivatives of monosaccharides as cell adhesion inhibitors
07/20/2000WO2000042044A1 Novel aralkyl amines of spirofuropyridines useful in therapy
07/20/2000WO2000042042A2 High affinity inhibitors for target validation and uses thereof
07/20/2000WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
07/20/2000WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
07/20/2000WO2000042034A1 Phenanthridine-n-oxides with pde-iv inhibiting activity
07/20/2000WO2000042026A1 Non-peptide glp-1 agonists
07/20/2000WO2000042024A1 Crystalline bis[(e)-7- [ 4-(4- fluorophenyl)- 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] (3r,5s)-3, 5-dihydroxyhept -6-enoic acid]calcium salt
07/20/2000WO2000042023A1 Substituted imidazoles, their preparation and use
07/20/2000WO2000042022A1 Benzoheterocycles and their use as mek inhibitors
07/20/2000WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity
07/20/2000WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
07/20/2000WO2000042011A1 Amide compounds
07/20/2000WO2000042009A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
07/20/2000WO2000042003A1 Benzenesulfonamide derivatives and their use as mek inhibitors
07/20/2000WO2000041994A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
07/20/2000WO2000041992A1 Reductive alkylation of secondary amines with hydrosilane
07/20/2000WO2000041740A2 Particles for oral delivery of peptides and proteins
07/20/2000WO2000041726A2 Noninvasive vascular therapy
07/20/2000WO2000041719A1 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
07/20/2000WO2000041707A2 USE OF $i(LACTOBACILLUS SALIVARIUS)
07/20/2000WO2000041705A1 Pre-conditioning against cell death
07/20/2000WO2000041701A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones for treating insulin dependent and non-insulin dependent diabetes
07/20/2000WO2000041692A2 Compositions having improved stability
07/20/2000WO2000041689A1 Telomerase inhibitors
07/20/2000WO2000041677A1 Granules for oral administration, process for producing the same, and tablets produced from the granules
07/20/2000WO2000041674A1 Use of a plant extract of the genus rosmarinus in compositions for treating ageing skin symptoms
07/20/2000WO2000041669A2 Benzimidazole vascular damaging agents
07/20/2000WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000WO2000041505A2 Anthranilic acid derivatives
07/20/2000WO2000041497A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
07/20/2000WO2000041472A2 Binding partners for 5-ht5-receptors for the treatment of migraine
07/20/2000WO2000041469A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS
1 ... 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 ... 1564